| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| 99mtc-mip-1407 | somatostatin receptor type 1 | NA | Successful target | TTD | Carcinoma Neuroendocrine[MeSHID:D018278] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | investigative | unknown |
| 99mtc-mip-1407 | somatostatin receptor type 2 | NA | Successful target | TTD | Carcinoma Neuroendocrine[MeSHID:D018278] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | investigative | unknown |
| 99mtc-mip-1407 | somatostatin receptor type 3 | NA | Successful target | TTD | Carcinoma Neuroendocrine[MeSHID:D018278] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | investigative | unknown |
| 99mtc-mip-1407 | somatostatin receptor type 4 | NA | Clinical trial target | TTD | Carcinoma Neuroendocrine[MeSHID:D018278] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | investigative | unknown |
| 99mtc-mip-1407 | somatostatin receptor type 5 | NA | Successful target | TTD | Carcinoma Neuroendocrine[MeSHID:D018278] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | investigative | unknown |
| click here to return to the previous page | ||||||||